To assess whether expression of the 9 AS targets was associated with variants at the splice sites, we analyzed 504 samples with matched tumor WGS data in our pediatric cancer cohort and did not find any significant association in two genes (FN1, VCAN) that harbored such variants (Supplementary Data 2). Here, FN1 is linked to cancer.